Home > PE Ratio > JENBURKT PHARMACEUTICALS

JENBURKT PHARMACEUTICALS
PE (Price/Earnings) Ratio

The Current P/E Ratio of JENBURKT PHARMACEUTICALS is 13.48.

Share Price ₹962.6Mar 11,2025
Market Cap ₹423.5 Cr
Earnings-TTM₹31.4 CrTTM-Standalone Results
Price/Earnings13.48xCalculated as Market Cap/Earnings
Explore Stock Analytics
COMMUNITY POLL
for JENBURKT PHARMACEUTICALS
Please provide your vote to see the results

Definition & Calculation of PE (Price/Earnings) ratio of JENBURKT PHARMACEUTICALS

Price-to-Earnings ratio, P/E Multiple, or P/E Ratio is an important valuation multiple that is defined as:

P/E = Market Capitalization / Net Income

or, using per-share numbers:

P/E = Stock Price / Earnings Per Share (EPS)

Applying the above formula, P/E ratio of JENBURKT PHARMACEUTICALS is calculated as :

Current Market Cap [ ₹423.5 Cr] as on Mar 11,2025

(/) Earnings [ ₹31.4 Cr] based on TTM-Standalone Results

(=) P/E Ratio [ 13.48x ]

P/E Ratio indicates the multiple of earnings investors are willing to pay to own one share of the company.

Thus, for JENBURKT PHARMACEUTICALS , the investors are currently willing to pay 13.48 times earnings to own 1 share of the company.

PE Multiples are the most widely used valuation multiple in practice.

Since P/E ratio uses Net Income in the calculation, P/E multiples are not always reliable for valuing companies with negative earnings.

In such cases, you may consider using Price to Book ratio or Price to Sales ratio of JENBURKT PHARMACEUTICALS !

P/E ratios, also, would not adjust for differences in the capital structure between companies.

The chart below summarizes the trend in P/E Ratio of JENBURKT PHARMACEUTICALS over the last five years.

Historical PE (Price/Earnings) ratio chart of JENBURKT PHARMACEUTICALS


PE Ratio Performance Analysis for JENBURKT PHARMACEUTICALS

- JENBURKT PHARMACEUTICALS 's latest p/e ratio is 13.48x.

- JENBURKT PHARMACEUTICALS 's p/e ratio for fiscal years ending Mar2024 to Mar2020 averaged 11.24x.

- JENBURKT PHARMACEUTICALS 's operated at median p/e ratio of 11.66x from fiscal years ending March 2018 to 2022.

- Looking back at the last 5 fiscal years, JENBURKT PHARMACEUTICALS 's p/e ratio peaked in Mar2023 at 11.94x.

- JENBURKT PHARMACEUTICALS 's p/e ratio hit its five-year low in Mar2020 of 9.81x.


How does JENBURKT PHARMACEUTICALS 's P/E Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?

Peer Comparison (Pharmaceuticals & Drugs Industry)Earnings-TTM (Cr)PE RatioMarket Cap
JENBURKT PHARMACEUTICALS 31.4113.48423.5
SUN PHARMACEUTICAL INDUSTRIES LTD11,486.0034.59397,246.0
DIVIS LABORATORIES LTD2,067.0071.18147,119.0
CIPLA LTD5,000.4323.36116,805.0
TORRENT PHARMACEUTICALS LTD1,862.0055.61103,554.0
DR REDDYS LABORATORIES LTD5,428.6017.1793,192.0
MANKIND PHARMA LTD2,050.7344.4791,196.4
ZYDUS LIFESCIENCES LTD4,591.8019.7290,551.0
LUPIN LTD2,892.1031.2090,226.2
AUROBINDO PHARMA LTD3,500.2518.1063,368.4
ABBOTT INDIA LTD1,334.4648.5864,826.7

Pharmaceuticals & Drugs Industry Benchmark (Top 10) PE Analysis vs JENBURKT PHARMACEUTICALS 's P/E Ratio

Top 10 Industry PeersPE Ratio
Min industry PE 13.48x
Max industry PE 71.18x
Median industry PE 31.20x
Average industry PE 34.31x



You may also like the below Video Courses